Prevention of Prematurity: Advances and Opportunities

Area of Science:

• Obstetrics and Gynecology
• Genetics
• Public Health

Background:

• Preterm birth (PTB) rates exhibit significant global variation and disparities across racial and ethnic groups.
• The complex etiology of PTB involves socioenvironmental, phenotypic, and genotypic factors, with limited understanding of causal mechanisms.
• Individual responses to existing medical interventions for PTB may be influenced by pharmacogenomic differences.

Purpose of the Study:

• To explore current and future strategies for preventing preterm birth (PTB).
• To highlight the role of pharmacogenomics in varied treatment responses.
• To emphasize the need for integrating sociodemographic, lifestyle, and genetic data in future PTB prevention.

Main Methods:

• Review of existing literature on PTB prevention strategies.
• Analysis of factors contributing to PTB, including socioenvironment, phenotype, and genotype.
• Discussion of the potential of pharmacogenomics in personalized PTB management.
• Exploration of statistical and big-data approaches for future research.

Main Results:

• Current PTB prevention focuses on minimizing iatrogenic births and risk reduction in high-risk individuals.
• Pharmacogenomics offers a potential explanation for differential responses to medical interventions.
• Future prevention will integrate comprehensive individual data, including sociodemographics, lifestyle, and genetic/epigenetic variations.

Conclusions:

• Effective PTB prevention requires a multifaceted approach considering individual variability.
• Advancements in understanding genetic and epigenetic factors are crucial for developing targeted preventive strategies.
• The integration of big-data analytics is essential for future PTB research and prevention efforts.